Ensuring an appropriate ethics oversight under the new EU Clinical Trial Regulation: challenges and practicalities
J Glasa, H Glasová - Clinical Therapeutics, 2017 - clinicaltherapeutics.com
Background: Imipenem is a broad-spectrum β-lactam antibiotic frequently used for infectious
complications in ICU patients. Dosing optimisation still remains challenging for clinicians …
complications in ICU patients. Dosing optimisation still remains challenging for clinicians …
Imipenem dosing in the obese and in patients with augmented renal clearance: a PK/PD analysis
H Suchánková, J Strojil - Clinical Therapeutics, 2017 - clinicaltherapeutics.com
Background Imipenem is a broad-spectrum β-lactam antibiotic frequently used for infectious
complications in ICU patients. Dosing optimisation still remains challenging for clinicians …
complications in ICU patients. Dosing optimisation still remains challenging for clinicians …
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients
J Bai, A Wen, Z Li, X Li, M Duan - European Journal of Hospital …, 2023 - ejhp.bmj.com
Objective The objective of this study was to explore factors that affect the clearance of
imipenem in critically ill patients and to provide a dosing regimen for such patients. Methods …
imipenem in critically ill patients and to provide a dosing regimen for such patients. Methods …
Pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with extracorporeal …
S Jaruratanasirikul, V Vattanavanit… - European Journal of …, 2020 - Springer
Background Extracorporeal membrane oxygenation (ECMO), a cardiopulmonary bypass
device, has been found to increase the profound pathophysiological changes associated …
device, has been found to increase the profound pathophysiological changes associated …
Parametric and nonparametric population pharmacokinetic models to assess probability of target attainment of imipenem concentrations in critically ill patients
Population pharmacokinetic modeling and simulation (M&S) are used to improve antibiotic
dosing. Little is known about the differences in parametric and nonparametric M&S. Our …
dosing. Little is known about the differences in parametric and nonparametric M&S. Our …
Population-based pharmacokinetics and dose optimization of imipenem in Vietnamese critically-ill patients
TD Dinh, HN Nguyen, BH Le, TTT Nguyen… - Infection and Drug …, 2022 - Taylor & Francis
Purpose The purpose of this study was to characterize the population-based
pharmacokinetic (POP-PK) profile of imipenem in Vietnamese adult patients and to assess …
pharmacokinetic (POP-PK) profile of imipenem in Vietnamese adult patients and to assess …
Imipenem population pharmacokinetics: therapeutic drug monitoring data collected in critically ill patients with or without extracorporeal membrane oxygenation
W Chen, D Zhang, W Lian, X Wang, W Du… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Carbapenem pharmacokinetic (PK) profiles are significantly different in critically ill patients
because of the drastic variability of the patients' physiological parameters. Published …
because of the drastic variability of the patients' physiological parameters. Published …
NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life‐threatening severe infections during support …
S Jaruratanasirikul, A Boonpeng… - … : The Journal of …, 2021 - Wiley Online Library
Abstract Study Objectives The objectives of this study were (i) to determine the population
pharmacokinetic (PK) of imipenem in critically ill patients with life‐threatening severe …
pharmacokinetic (PK) of imipenem in critically ill patients with life‐threatening severe …
Is continuous infusion of imipenem always the best choice?
H Suchánková, M Lipš, K Urbánek, MN Neely… - International journal of …, 2017 - Elsevier
Monte Carlo simulations allow prediction and comparison of concentration–time profiles
arising from different dosing regimens in a defined population, provided a population …
arising from different dosing regimens in a defined population, provided a population …
Imipenem dosing recommendations for patients undergoing continuous renal replacement therapy: systematic review and Monte Carlo simulations
D Rungkitwattanakul, T Charoensareerat… - Renal Replacement …, 2021 - Springer
Background The appropriate dosing of imipenem for critically ill AKI patients undergoing
CRRT remains scarce. Purpose This study aimed to (1) gather the available published …
CRRT remains scarce. Purpose This study aimed to (1) gather the available published …